PapersPMID:25297064
Effect of an α-lactalbumin-enriched infant formula supplemented with oligofructose on fecal microbiota, stool characteristics, and hydration status: a randomized, double-blind, controlled trial.
No finding here moved its endpoint.
What did not
1 findingHow to read these marks →“At week 8, there was no significant difference in the mean number of stools passed in a 24-hour period by infants in the EF and CF groups (mean ± SE: EF group 1.59 ± 0.43 stools/d vs CF group 2.18 ± 0.32 stools/d, P =.28).”
- Study
- RCT
- Duration
- 8 weeks
- Interests
- An author is affiliated with a producer
- Dose studied
- 3.0 g/L in infant formula, fed ad libitum for 8 weeks
- Population
- Healthy term formula-fed infants, per-protocol population, week 8; both arms fed an alpha-lactalbumin-enriched bovine milk formula, the control without oligofructose
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Healthy term infants in the United States, formula-fed (randomized) or human milk-fed (non-randomized reference), enrolled at 5 to 14 days of age; subject exposure is oligofructose (Orafti P95) added to an alpha-lactalbumin-enriched formula
- Participants
- 145
- Comparator
- an active treatment / no treatment / placebo
- Duration
- 56 days
- Endpoints measured
- 36